High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes

Brain Research Bulletin

Volumn 88, Issue 4, 2012, Pages 332-337

  Ren, Peng Cheng ^a   Zhang, Yong ^a   Zhang, Xu Dong ^a   An, Li Jun ^a   Lv, Hai Gang ^a   He, Jun ^a   Gao, Chang Jun ^a   Sun, Xu De ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Astrocyte; Diabetes; High mobility group box 1; Pain; Spinal dorsal horn

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC PAIN; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CHRONIC PAIN; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 84862220100     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.03.002     Document Type: Article

References (30)

1. Andersson A., Covacu R., Sunnemark D., Danilov A.I., Dal Bianco A., Khademi M., Wallstrom E., Lobell A., Brundin L., Lassmann H., Harris R.A. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J. Leukoc. Biol. 2008, 84:1248-1255.
2. Barrett A.M., Lucero M.A., Le T., Robinson R.L., Dworkin R.H., Chappell A.S. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007, 8(Suppl 2):S50-S62.
3. Basbaum A.I., Bautista D.M., Scherrer G., Julius D. Cellular and molecular mechanisms of pain. Cell 2009, 139:267-284.
4. Bettoni I., Comelli F., Rossini C., Granucci F., Giagnoni G., Peri F., Costa B. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 2008, 56:1312-1319.
5. Chacur M., Milligan E.D., Gazda L.S., Armstrong C., Wang H., Tracey K.J., Maier S.F., Watkins L.R. A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain 2001, 94:231-244.
6. Choudhury D., Tuncel M., Levi M. Diabetic nephropathy - a multifaceted target of new therapies. Discov. Med. 2011, 10:406-415.
7. Currie C.J., Poole C.D., Woehl A., Morgan C.L., Cawley S., Rousculp M.D., Covington M.T., Peters J.R. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet. Med. 2007, 24:187-194.
8. Gao Y.J., Ji R.R. Activation of JNK pathway in persistent pain. Neurosci. Lett. 2008, 437:180-183.
9. Gao Y.J., Ji R.R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol. Ther. 2010, 126:56-68.
10. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ. Res. 2010, 107:1058-1070.
11. Guo L.H., Schluesener H.J. The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors. Cell. Mol. Life Sci. 2007, 64:1128-1136.
12. Guo W., Wang H., Watanabe M., Shimizu K., Zou S., LaGraize S.C., Wei F., Dubner R., Ren K. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J. Neurosci. 2007, 27:6006-6018.
13. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 1980, 67:313-316.
14. Kim D., Kim M.A., Cho I.H., Kim M.S., Lee S., Jo E.K., Choi S.Y., Park K., Kim J.S., Akira S., Na H.S., Oh S.B., Lee S.J. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem. 2007, 282:14975-14983.
15. Kim J.B., Lim C.M., Yu Y.M., Lee J.K. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. J. Neurosci. Res. 2008, 86:1125-1131.
16. Larsson M., Broman J. Synaptic plasticity and pain: role of ionotropic glutamate receptors. Neuroscientist 2010.
17. Liao Y.H., Zhang G.H., Jia D., Wang P., Qian N.S., He F., Zeng X.T., He Y., Yang Y.L., Cao D.Y., Zhang Y., Wang D.S., Tao K.S., Gao C.J., Dou K.F. Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes. Brain Res. 2010, 1368:324-335.
18. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
19. Nogueira-Machado J.A., Volpe C.M., Veloso C.A., Chaves M.M. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin. Ther. Targets 2011, 15:1023-1035.
20. Pedrazzi M., Patrone M., Passalacqua M., Ranzato E., Colamassaro D., Sparatore B., Pontremoli S., Melloni E. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J. Immunol. 2007, 179:8525-8532.
21. Ren Y.S., Qian N.S., Tang Y., Liao Y.H., Yang Y.L., Dou K.F., Toi M. Sodium channel Nav1.6 is up-regulated in the dorsal root ganglia in a mouse model of type 2 diabetes. Brain Res. Bull. 2012, 87:244-249.
22. Shibasaki M., Sasaki M., Miura M., Mizukoshi K., Ueno H., Hashimoto S., Tanaka Y., Amaya F. Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain 2010, 149:514-521.
23. Singh D.K., Winocour P., Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat. Rev. Endocrinol. 2011, 7:176-184.
24. Tang D., Kang R., Zeh H.J., Lotze M.T. High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal. 2011, 14:1315-1335.
25. Tong W., Wang W., Huang J., Ren N., Wu S.X., Li Y.Q. Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain. Biochem. Biophys. Res. Commun. 2010, 395:572-576.
26. Toth C., Rong L.L., Yang C., Martinez J., Song F., Ramji N., Brussee V., Liu W., Durand J., Nguyen M.D., Schmidt A.M., Zochodne D.W. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 2008, 57:1002-1017.
27. Wang W., Mei X., Huang J., Wei Y., Wang Y., Wu S., Li Y. Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain. PLoS ONE 2009, 4:e6973.
28. Wang W., Mei X.P., Wei Y.Y., Zhang M.M., Zhang T., Xu L.X., Wu S.X., Li Y.Q. Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain. Brain Behav. Immun. 2011, 25:1355-1366.
29. Wang W., Petralia R.S., Takamiya K., Xia J., Li Y.Q., Huganir R.L., Tao Y.X., Yaster M. Preserved acute pain and impaired neuropathic pain in mice lacking protein interacting with C Kinase 1. Mol. Pain 2011, 7:11.
30. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.